Skip to content

Study · Measured the body's own peptide · 2018

1 result

A novel mechanism of tumor-induced thymic atrophy in mice bearing H22 hepatocellular carcinoma.

Sun S, Ji H, Feng Y, Kang Y, Yu J, Liu A

Cancer management and research5 Mar 2018Cited by 9 (Europe PMC)

PMID29551914 (opens in a new tab)PMCIDPMC5842769 (opens in a new tab)DOI10.2147/cmar.s157512 (opens in a new tab)PepBankPUB-29551914
Read at sourcePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01AnimalEndogenous levelAnimal study (in vivo)Other

    In mice bearing H22 hepatocellular carcinoma, the body's own thymosin alpha‑1 level in the thymus was higher than in control mice.

    In plain wordsIn mice with liver tumors, the body's own thymosin alpha‑1 level in the thymus was higher than in control mice.

    Peptide
    Thymosin alpha-1
    Outcome
    IncreaseThymic level of thymosin alpha 1
    Study

    mousen: not reported in source

    H22 hepatocellular carcinoma-bearing mice
    Comparator
    Control mice
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    the level of thymosin alpha 1 (Tα1) and the expression of Wnt4 in thymus of H22-bearing mice were significantly improved than control

    This result measures the body's own Thymosin alpha-1. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 08:55 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.